Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01475747 · ClinicalTrials.gov registry record
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 595
- Enrollment target
NCT01475747 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 595 participants.
The verdict
NCT01475747 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 595 participants
- Enrollment target
Study Summary
Systolic Pressure Intervention Trial (SPRINT) is a large scale randomized trial of \~ 9250 adults aged 50 years or older with high cardiovascular risk sponsored by NIH. The study is designed to recruit 45% of the study population with Chronic Kidney Disease (CKD). The trial will test the effects of low systolic blood pressure (SBP) goal of \< 120 mm Hg versus the standard goal of \< 140 mm Hg on the primary composite of cardiovascular events and death. One of the pre-specified secondary outcome is the progression of kidney disease. In this ancillary named SPRINT - Factors affecting Atherosclerosis STudy (FAST), the investigators plan to take advantage of the unique opportunities afforded by the parent study to examine issues that are of significant public health importance. This is an observational study in SPRINT participants. This study will examine mechanistically, the factors affecting the progression of atherosclerosis in CKD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 595 participants |
| Start Date | 2011-09 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01475747
The ClinicalTrials.gov registry entry for NCT01475747 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 595 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01475747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01475747 about?
NCT01475747 is a clinical study titled "Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study". Systolic Pressure Intervention Trial (SPRINT) is a large scale randomized trial of \~ 9250 adults aged 50 years or older with high cardiovascular risk sponsored by NIH. The study is designed to recruit 45% of the study population with Chronic Kidney Disease (CKD). The trial will test the effects of ...
What is the current status of trial NCT01475747?
This trial is currently completed. The enrollment target is 595 participants. The study started on 2011-09. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01475747?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.